Concepedia

Luciane Pons DiLeone

LP

Statistics

Publications

5

Citations

306

H-Index

5

Active since

2000

Affiliations

Universidade Federal do Rio Grande do Sul(Current)

Universidade Luterana do Brasil

Luciane Pons DiLeone is an author at Universidade Federal do Rio Grande do Sul specializing in pharmacology, oncology, and chemotherapy.

Publications per year

2000–2006

5

Publications

5

A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer

Gilberto Schwartsmann, Holger J. Schünemann, Chistopher Gorini et al. · Investigational New Drugs · 2000 · 111 citations

, , +13

Phase II Trial of Cisplatin Plus Decitabine, a New DNA Hypomethylating Agent, in Patients With Advanced Squamous Cell Carcinoma of the Cervix

Paula R. Pohlmann, Luciane Pons DiLeone, Anna Cancella et al. · American Journal of Clinical Oncology · 2002 · 86 citations

, , +16

A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies

Gilberto Schwartsmann, Luciane Pons DiLeone, Marc E. Horowitz et al. · Investigational New Drugs · 2006 · 76 citations

, , +6

Fractionated Doses of Oral Etoposide in the Treatment of Patients With AIDS-Related Kaposi Sarcoma

Eduardo Sprinz, Ana Paula Ferrary Caldas, D.R.A. Mans et al. · American Journal of Clinical Oncology · 2001 · 20 citations

, , +17

Quantification of the bombesin/gastrin releasing peptide antagonist RC-3095 by liquid chromatography–tandem mass spectrometry

Alberto dos Santos Pereira, Luciane Pons DiLeone, Fabiano H. Souza et al. · Journal of Chromatography B · 2004 · 13 citations · Full text

, , +7

1–5 of 5